Expression Patterns of Micro-RNAs 146a, 181a, and 155 in Subacute Sclerosing Panencephalitis
Abstract
Subacute sclerosing panencephalitis is caused by persistent brain infection of mutated virus, showing inflammation, neurodegeneration, and demyelination. Although many factors are emphasized in the pathogenesis of subacute sclerosing panencephalitis, the exact mechanism of neurodegeneration remains unknown. Micro-RNAs are small, noncoding RNAs that regulate gene expression at the posttranscriptional levels. Micro-RNAs are essential for normal immune system development; besides they are also implicated in the pathogenesis of many chronic inflammatory disorders. The aim of this study is to investigate the expression patterns of micro-RNAs 146a, 181a, and 155 in peripheral blood mononuclear cells of patients with subacute sclerosing panencephalitis. We enrolled 39 patients with subacute sclerosing panencephalitis and 41 healthy controls. Quantitative analysis of micro-RNAs 146a, 181a, and 155 were performed using specific stem-loop primers followed by real-time polymerase chain reaction. All of 3 micro-RNAs were upregulated in subacute sclerosing panencephalitis patients. In addition, the level of micro-RNA 155 expression was higher in stage 3 patients. But, micro-RNA 146a and 181a expression levels showed no association or correlation with clinically relevant data. Alteration of peripheral blood mononuclear cell micro-RNAs in subacute sclerosing panencephalitis may shed new light on the pathogenesis of disease and may contribute to the aberrant systemic rise in mRNA levels in subacute sclerosing panencephalitis.
Get full access to this article
View all access and purchase options for this article.
References
1. Gutierrez J, Issacson RS, Koppel BS. Subacute sclerosing panencephalitis: an update. Dev Med Child Neurol. 2010;52:901–907.
2. Zilber N, Kahana E. Environmental risk factors for subacute sclerosing panencephalitis (SSPE). Acta Neurol Scand. 1998;98:49–54.
3. Campbell H, Andrews N, Brown KE, Miller E. Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol. 2007;36:1334–1348.
4. Anlar B, Kose G, Gurer Y, Altunbasak S, Haspolat S, Okan M. Changing epidemiological features of subacute sclerosing panencephalitis. Infection. 2001;29:192–195.
5. Campbell C, Levin S, Humphreys P, Walop W, Brannan R. Subacute sclerosing panencephalitis: results of the Canadian Paediatric Surveillance Program and review of the literature. BMC Pediatr. 2005;5:47.
6. Tuxhorn IE. Familial subacute sclerosing panencephalitis in two siblings. Pediatr Neurol. 2004;31:291–294.
7. Hayashi M, Arai N, Satoh J, et al. Neurodegenerative mechanisms in subacute sclerosing panencephalitis. J Child Neurol. 2002;17:725–730.
8. Anlar B, Söylemezoğlu F, Aysun S, Köse G, Belen D, Yalaz K. Tissue inflammatory response in subacute sclerosing panencephalitis [SSPE]. J Child Neurol. 2001;16:895–900.
9. Nagano I, Nakamura S, Yoshioka M, Onodera J, Kogure K, Itoyama Y. Expression of cytokines in brain lesions in subacute sclerosing panencephalitis. Neurology. 1994;44:710–715.
10. Piskin IE, Karakas-Celik S, Calik M, et al. Association of interleukin 18, interleukin 2, and tumor necrosis factor polymorphisms with subacute sclerosing panencephalitis. DNA Cell Biol. 2013;32:336–340.
11. Yilmaz V, Demirbilek V, Gürses C, et al. Interleukin IL-12, IL-2, interferon-gamma gene polymorphisms in subacute sclerosing panencephalitis patients. J Neurovirol. 2007;13:410–415.
12. Anlar B, Söylemezoğlu F, Elibol B, et al. Apoptosis in brain biopsies of subacute sclerosing panencephalitis patients. Neuropediatrics. 1999;30:239–242.
13. McQuaid S, McMahon J, Herron B, Cosby SL. Apoptosis in measles virus-infected human central nervous system tissues. Neuropathol Appl Neurobiol. 1997;23:218–224.
14. Anlar B, Beken S, Talim B. Apoptosis in subacute sclerosing panencephalitis: possibility for treatment. Med Hypotheses. 2013;80:507–508.
15. Tatli B, Ekici B, Ozmen M. Flupirtine may stop the progressive course of subacute sclerosing panencephalitis. Med Hypotheses. 2010;75:576–577.
16. Lu FL, Liston A. MicroRNA in the immune system, MicroRNA as an immune system. Immunology. 2009;127:291–298.
17. Iborra M, Bernuzzi F, Invernizzi P, Danese S. MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response. Autoimmun Rev. 2012;11:305–314.
18. Sonkoly E, Stahle M, Pivarcsi A. MicroRNAs and immunity: Novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol. 2008;18:131–140.
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2[-Delta Delta C[T]] Method. Methods. 2001;25:402–408.
20. Hara T, Yamashita S, Aiba H, et al. Measles virus-specific T helper 1 / T helper 2-cytokine production in subacute sclerosing panencephalitis. J Neurovirol. 2000;6:121–126.
21. Costinean S, Zanesi N, Pekarsky Y, et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E[mu]-miR155 transgenic mice. Proc Natl Acad Sci USA. 2006;103:7024–7029.
22. Rodriguez A, Vigorito E, Clare S, et al. Requirement of bic/microRNA-155 for normal immune function. Science. 2007;316:608–611.
23. Kohlhaas S, Garden OA, Scudamore C, Turner M, Okkenhaug K, Vigorito E. Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells. J Immunol. 2009;182:2578–2582.
24. O’Connell RM, Kahn D, Gibson WS, et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity. 2010;33:607–619.
25. Lu C, Huang X, Zhang X, et al. miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood. 2011;117:4293–4303.
26. Aydin OF, Ichiyama T, Anlar B. Serum and cerebrospinal fluid cytokine concentrations in subacute sclerosing panencephalitis. Brain Dev. 2010;32:463–466.
27. Li QJ, Chau J, Ebert PJ, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell. 2007;129:147–161.
28. Ouyang YB, Lu Y, Yue S, Giffard RG. miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. Mitochondrion. 2012;12:213–219.
29. Caksen H, Ozkan M, Cemek M, Cemek F. Oxidant and antioxidant status in children with subacute sclerosing panencephalitis. J Child Neurol. 2013 Jul 19. [Epub ahead of print]
30. Lu LF, Boldin MP, Chaudhry A, et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell. 2010;142:914–929.
31. Quinn EM, Wang JH, O'Callaghan G, Redmond HP. MicroRNA-146a is upregulated by and negatively regulates TLR2 signaling. PLoS One. 2013;8:e62232.
Cite article
Cite article
Cite article
OR
Download to reference manager
If you have citation software installed, you can download article citation data to the citation manager of your choice
Information, rights and permissions
Information
Published In
Article first published online: April 30, 2014
Issue published: January 2015
Keywords
PubMed: 24789113
Authors
Author Contributions
UY reviewed the patient’s medical charts and wrote the first draft of the manuscript. UKT and ŞG made microRNA measurements. KBÇ, YT, and EB collected data and modified subsequent drafts. SHK supervised and provided mentorship for completion of the manuscript.
Metrics and citations
Metrics
Article usage*
Total views and downloads: 120
*Article usage tracking started in December 2016
Articles citing this one
Receive email alerts when this article is cited
Web of Science: 6 view articles Opens in new tab
Crossref: 6
- Small Non-coding RNA Expression Following Respiratory Syncytial Virus ...
- Antiviral microRNA Expression Signatures are Altered in Subacute Scler...
- The miR-155 regulates cytokines expression by SOSC1 signal pathways of...
- IL28B, IL29 and micro-RNA 548 in subacute sclerosing panencephalitis a...
- MiRNA-124 is a link between measles virus persistent infection and cel...
- miR-155 Inhibits Nucleus Pulposus Cells’ Degeneration through Targetin...
Figures and tables
Figures & Media
Tables
View Options
Get access
Access options
If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:
loading institutional access options
Alternatively, view purchase options below:
Purchase 24 hour online access to view and download content.
Access journal content via a DeepDyve subscription or find out more about this option.
